JUN 11, 2016 10:03 AM PDT

New Agent Absorbs Toxic Drugs to Reduce Chemo Harm

WRITTEN BY: Xuan Pham
Killing cancer is only half the battle. Sparing healthy cells and tissues while defeating cancer is the other half that’s more difficult than it sounds. Scientists have attempted to solve this problem by making drugs that specifically target only the cancer cells. But researchers at the Lawrence Berkeley National Laboratory are taking a different approach. They’ve developed the equivalent of a chemical “sponge” that’s designed to soak up excess toxic anti-cancer drugs before it can harm healthy cells.
 
Roy Kaltschmidt/Berkeley LabThe chemical sponge is known formally as the ChemoFilter. It works by containing molecules with a strong affinity to the chemotherapeutic agent. In the picture shown here, the polymer material turns from a yellowish hue to a red after it binds chemotherapy drugs.
 
The idea for the first generation of ChemoFilters came about when researchers were working on polymer membranes. "We used to use this material for transporting protons in a fuel cell," said Xi Chen, who is co-author of the study. "I was really excited when I found out this could be used for chemotherapy -- this was branching out in a totally different direction."
 
Chen and the team realized that certain components of the polymer membrane had a strong negative electric charge. Like a magnet, the material works nicely to attract chemotherapy drugs that have a strong positive charge.
 
Doxorubicin, a common chemotherapy agent that’s positively charged, was a fitting model drug to test their ChemoFilter system. "In our lab experiments, the current design can absorb 90 percent of the drug in 25-30 minutes," said Chen.
 
"Doxorubicin has been around for decades. It is very well understood, and it is also very toxic," said Steven Hetts, associate professor at the University of California San Francisco, and who was the mastermind behind the ChemoFilter system. "If you get exposed to too much, when it goes through the heart you can go into heart failure.” Having a sponge that can soak up excess toxin could transform how doctors use this drug.
 


But an obvious concern is whether the sponge could negate the anti-cancer effects of the drugs on the actual tumor. For example, if the ChemoFilter is administered too soon then the chemotherapy agent won’t have enough time to act on the tumor. Timing, then, will be a crucial component to this new technology.
 
After demonstrating its effectiveness in animal studies, the ChemoFilter system received a patent from the FDA in April. The team is hopeful clinical trials will begin soon to test the device in patients. And if the device works as it’s supposed to, the team thinks it could actually increase the effectiveness of current drugs. “If you can remove a lot of the drug, you could escalate the dose of the drug you can give, for better tumor control and potentially a cure -- and you could basically eliminate any side effects,” said Hetts. 

Additional source: Science Daily
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 30, 2020
Cancer
Fighting mesothelioma with curcumin
OCT 30, 2020
Fighting mesothelioma with curcumin
Research led by investigators at Flinders University in Australia is spearheading new developments in cancer prevention ...
DEC 03, 2020
Cancer
Lung cancers in Latin Americans with Native American ancestry
DEC 03, 2020
Lung cancers in Latin Americans with Native American ancestry
New research published in Cancer Discovery highlights the increased presence of genetic mutations in Latin American lung ...
DEC 21, 2020
Cancer
Cancer survivors have a higher risk of developing subsequent primary cancers
DEC 21, 2020
Cancer survivors have a higher risk of developing subsequent primary cancers
New research published in JAMA has found that cancer survivors have a higher risk of developing subsequent primary cance ...
DEC 28, 2020
Drug Discovery & Development
Anti-Diarrhea Drug Kills Aggressive Brain Cancer Cells
DEC 28, 2020
Anti-Diarrhea Drug Kills Aggressive Brain Cancer Cells
Glioblastoma is a very aggressive and lethal form of brain cancer that responds poorly to chemotherapy in children and a ...
JAN 02, 2021
Cancer
Mothers and fathers take the financial toll of having a child with cancer differently
JAN 02, 2021
Mothers and fathers take the financial toll of having a child with cancer differently
A new study by researchers at Uppsala University in Sweden contemplates the socioeconomic impact on parents of having a ...
JAN 05, 2021
Cancer
Two gene expression subtypes identified in peritoneal carcinomatosis cells
JAN 05, 2021
Two gene expression subtypes identified in peritoneal carcinomatosis cells
New research published in Nature Medicine finds two subtypes of gene expression in peritoneal carcinomatosis (PC) that c ...
Loading Comments...